| NVO Snapshot | |
|---|---|
| Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark. | |
| VALUATION DATA | |
| Market Capitalization | $558,851,293,000 | Price to Sales | 1.00 |
| Earnings per Share | $2.6600 |
| PE Ratio | 47.09 |
| PRICE DATA | |
| Most Recent Close | $128.6400 |
| 52 Week High | $2.431 |
| 52 Week Low | $36.21 |
| 50-Day Moving Average | $2.429 |
| 200-Day Moving Average | $4.921 |
| All data are from Alpha Vantage as of today. For more infomation on NVO see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search